Strategies for Managing Anemia in Hepatitis C Patients Undergoing Antiviral Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strategies for Managing Anemia in Hepatitis C Patients Undergoing Antiviral Therapy

Published:2007-04 Issue:4 Volume:102 Page:880-889
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

McHutchison John G.,Manns Michael P.,Brown Robert S.,Reddy K. Rajender,Shiffman Mitchell L.,Wong John B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference60 articles.

1. Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

3. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

4. Evaluation of the safety and efficacy of once-weekly PEG/interferon alfa-2A (PEGASYS™) for chronic hepatitis C. A multinational, randomized study

5. Pegylated interferon alfa-2B (PEG-intron) mono-therapy is superior to interferon alfa-2B (intron A) for the treatment of chronic hepatitis C

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Analysis of Antiviral Drugs Approved for COVID-19 in Saudi Arabia;International Journal of Pharmacology;2023-05-01

2. A brief overview on current status of nanomedicines for treatment of pancytopenia: Focusing on chemotherapeutic regime;Journal of Drug Delivery Science and Technology;2021-02

3. The effects of favipiravir on hematological parameters of covıd-19 patients;Revista da Associação Médica Brasileira;2020

4. Simple predictor for anemia in chronic hepatitis C patients receiving peginterferon plus ribavirin;Advances in Digestive Medicine;2016-03

5. Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients;Clinical Journal of Gastroenterology;2015-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3